Mechanism of Action of Magnesium Sulfate
Magnesium sulfate acts through multiple mechanisms including blocking neuromuscular transmission by decreasing acetylcholine release at the motor end-plate, antagonizing NMDA receptors in the central nervous system, blocking calcium channels, producing peripheral vasodilation, and exerting anti-inflammatory effects on the brain.
Primary Mechanisms
Neuromuscular Blockade
Magnesium prevents or controls convulsions by blocking neuromuscular transmission and decreasing the amount of acetylcholine liberated at the end-plate by the motor nerve impulse 1. This peripheral effect contributes to its anticonvulsant properties, particularly in eclampsia prevention.
Central Nervous System Effects
NMDA receptor antagonism: Magnesium acts as a voltage-dependent blocker of NMDA (N-methyl-D-aspartate) receptors, which are excitatory amino acid receptors in the brain 2. This mechanism elevates seizure threshold and provides resistance to electrically and chemically stimulated seizures.
CNS depression: Magnesium has a depressant effect on the central nervous system, though it does not adversely affect the woman, fetus, or neonate when used appropriately in eclampsia or pre-eclampsia 1.
Cardiovascular Mechanisms
Magnesium acts as a calcium channel blocker and cerebral vasodilator 3, 4. It produces peripheral vasodilation—with low doses causing only flushing and sweating, while larger doses lower blood pressure 1. The calcium channel inhibition appears most relevant for its antiarrhythmic actions 4.
Neuroprotective Effects in Preterm Birth
For fetal neuroprotection, the mechanism is likely multifactorial and includes:
- Reduction of neuroinflammation: In animal models of severe preeclampsia, magnesium sulfate dramatically reduced microglial activation from 35% to 6%, reversing the neuroinflammatory state without necessarily affecting blood-brain barrier permeability 5
- Cerebrovascular effects: May relieve vasoconstriction and protect the blood-brain barrier 6
- Anti-inflammatory properties: Contributes to neuroprotection in the developing fetal brain 7
Pharmacokinetics and Therapeutic Levels
- Onset of action: Immediate with IV administration (lasts ~30 minutes); approximately 1 hour with IM administration (persists 3-4 hours) 1
- Therapeutic anticonvulsant levels: 2.5 to 7.5 mEq/L (normal plasma levels: 1.5 to 2.5 mEq/L) 1
- Excretion: Solely by the kidneys at a rate proportional to plasma concentration and glomerular filtration 1
Clinical Correlation with Plasma Levels
The dose-response relationship is clinically important:
- >4 mEq/L: Deep tendon reflexes decrease
- ~10 mEq/L: Reflexes disappear; respiratory paralysis may occur
- ~10 mEq/L or lower: Heart block may occur
- >12 mEq/L: May be fatal 1
Important Caveats
Calcium antagonizes magnesium toxicity: The central and peripheral effects of magnesium poisoning are antagonized to some extent by IV administration of calcium 1. This is critical for managing magnesium overdose.
Renal function is essential: Since magnesium is excreted solely by the kidneys, toxic effects can occur in the presence of renal impairment 8. Appropriate monitoring of renal function and magnesium levels is mandatory during prolonged infusions.